Top Markets
#1 Akedo Akedo +63.33%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.58%
#4 Cross Cross +34.01%
#5 Black Phoenix Black Phoenix +33.94%
#6 Cap Cap +32.66%
#7 Velvet Velvet +25.73%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.06%
#9 Ravencoin Ravencoin +13.84%
#10 DoubleZero DoubleZero +13.55%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Valion Bio, Inc. Valion Bio, Inc.

Valion Bio, Inc.

VBIO
Classement en actions #38911
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead... Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Prix de l'action
$0.1645
Capitalisation boursière
$681.26K
Changement (1 jour)
-3.69%
Changement (1 an)
-95.30%
Pays
US
Échange Valion Bio, Inc. (VBIO)

Catégorie

Healthcare
Historique du prix de l'action pour Valion Bio, Inc. (VBIO)
Prix de clôture le plus élevé : $0.24 le 2026-08-01

Prix de clôture le plus bas : $7.60K le 2021-11-01
Historique du prix de l'action de Valion Bio, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -21.26%
2025 -56.71%
2024 -86.09%
2023 -97.85%
2022 -79.33%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $507.84 30.12%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $845.14 29.54%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $728.57 6.67%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $252.77 11.67%
BE